Garfield Alastair
Chief Scientific Officer · 7 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Tax withholding | 2,150 | $110.41 | $237,381.50 | filing |
| 2026-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Option exercise | 4,445 | — | — | filing |
| 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Tax withholding | 2,026 | $108.99 | $220,813.74 | filing |
| 2026-02-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Option exercise | 6,663 | — | — | filing |
| 2025-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Sale | 1,313 | $64.81 | $85,095.53 | filing |
| 2025-07-02 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Sale | 6 | $64.60 | $387.60 | filing |
| 2025-07-01 | RYTM | RHYTHM PHARMACEUTICALS, INC. | Option exercise | 4,445 | — | — | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.